{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-027233","form_type":"8-K","ticker":"TVRD","cik":"0001346830","company_name":"Tvardi Therapeutics, Inc.","filed_at":"2025-03-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.402708+00:00","generated_at":"2026-05-24T06:23:04.183876+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Cara issues supplemental disclosures for Tvardi merger after stockholder lawsuits","bullets":["Received 13 demands and 2 lawsuits (filed Mar 5-6, 2025) claiming proxy omitted material info.","Combined company board to have 5 Tvardi designees, 1 Cara designee (Susan Shiff), 1 vacancy.","Piper Sandler valuation analyses updated with detailed peer comparisons and IPO precedent tables.","Cara denies violations but provides supplements to avoid litigation expense and merger disruption."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-027233","json":"https://secwatch.observer/filing/0001104659-25-027233.json","markdown":"https://secwatch.observer/filing/0001104659-25-027233.md","text":"https://secwatch.observer/filing/0001104659-25-027233.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1346830/000110465925027233/0001104659-25-027233-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1346830/000110465925027233/tm259994d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T06:23:04.183876+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}